Latest filing published 07 Dec 2021 for CRISPR Therapeutics AG, €771k.
Filing timeline
BuySaleInsider track record
Tony W. Ho: trading record in brief
Tony W. Ho (senior executive) discloses dealings in CRISPR Therapeutics AG to SEC (Form 4). We count 27 filings; the first trade dates from 1 August 2018 and the latest from 6 December 2021.
Every open-market trade on record is a sale: 13 sales worth €3.8M. The rest of the record consists of 7 share grants and 7 option exercises.
The record was last updated on 7 December 2021 with a share grant (€771k) in CRISPR Therapeutics AG. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Tony W. Ho
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,607 shares@ US$69.1711.0% of flowCommon SharesSEC:0001209191-21-068454:1
- 26,667 sharesCommon SharesSEC:0001209191-21-068454:0
- 2,141 shares@ US$124.153.2% of flowCommon SharesSEC:0001209191-21-020250:1
- 4,583 sharesCommon SharesSEC:0001209191-21-020250:0
- 1,585 shares@ US$114.652.2% of flowCommon SharesSEC:0001209191-21-019157:1
- 3,333 sharesCommon SharesSEC:0001209191-21-019157:0
- 23,551 shares@ US$16.907.8% of flowCommon SharesSEC:0001209191-20-064857:0
- 1,700 shares@ US$148.114.9% of flowCommon SharesSEC:0001209191-20-064857:1
- 900 shares@ US$149.182.6% of flowCommon SharesSEC:0001209191-20-064857:2
- 1,600 shares@ US$150.164.7% of flowCommon SharesSEC:0001209191-20-064857:3
- 1,100 shares@ US$151.583.3% of flowCommon SharesSEC:0001209191-20-064857:4
- 500 shares@ US$152.411.5% of flowCommon SharesSEC:0001209191-20-064857:5
- 5,000 shares@ US$149.7314.7% of flowCommon SharesSEC:0001209191-20-064857:8
- 2,951 shares@ US$150.618.7% of flowCommon SharesSEC:0001209191-20-064857:9
- 1,400 shares@ US$147.054.0% of flowCommon SharesSEC:0001209191-20-064857:6
- 8,400 shares@ US$148.3824.4% of flowCommon SharesSEC:0001209191-20-064857:7
- 229 shares@ US$70.140.3% of flowCommon SharesSEC:0001209191-20-038761:0
- 6,929 shares@ US$75.2011.0% of flowCommon SharesSEC:0001209191-20-038761:1
- 600 shares@ US$70.050.9% of flowCommon SharesSEC:0001209191-20-032312:0
- 6,100 shares@ US$70.149.3% of flowCommon SharesSEC:0001209191-20-032312:1
- 1,563 shares@ US$52.641.5% of flowCommon SharesSEC:0001209191-20-017240:1
- 3,333 sharesCommon SharesSEC:0001209191-20-017240:0
- 37,500 sharesCommon SharesSEC:0001209191-19-044652:0
- 14,534 shares@ US$52.5611.8% of flowCommon SharesSEC:0001209191-19-044652:1
- 10,000 shares@ US$40.876.2% of flowRestricted Stock UnitsSEC:0000899243-19-006649:0
25 of 27 declarations
